← Back to SLXN

Silexion Therapeutics Corp - Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 13/05/2025
$0$0$0$0$0$0$0$0
−$3.6−$2.7−$3.3−$2.5−$1.7−$12−$1.5−$1.4
$5.17$8.46$2.88$43.19$38.39$274.25$197.80$12.29
0.70.31.10.10.1

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.